secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001104659-22-082813
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NWBO eliminates Series A/B Preferred, creates Series C Preferred (10M shares)
-----------------------------------------------------------------------------

- Filed Certificate of Elimination for Series A and B Preferred Stock on July 20, 2022; no shares outstanding.
- Created Series C Preferred Stock with 10M shares, $0.001 par value, rights and preferences established.
- Series C created from authorized but unissued preferred shares; effective July 20, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/0001104659-22-082813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/tm2221829d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-082813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer